Clin2
NCT07024303Worth exploringNot yet recruiting

Measuring treatment effects for children with autism and behavior challenges

Challenging BehaviorAutism Spectrum Disorder

Part of Mental health clinical trials.

This study aims to measure how well different treatments work for young children with autism and intellectual disability who have challenging behaviors like aggression or self-injury. It may help you and your child find a treatment that reduces these behaviors and improves daily life.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
20 people
Ages
2 years to 12 years
Study type
Interventional

Who can take part

  • You must be the parent or legal guardian of a child who is in the study.
  • The child must be between 2 and 12 years old.
  • The child must have both autism and an intellectual disability (moderate, severe, or profound).
  • The child must show at least one challenging behavior such as aggression, self-injury, destruction, running away, or refusal.
  • English must be the main language spoken at home.
  • You must be thinking about trying medication, behavioral therapy, or both for the child's behavior.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07091279Recruiting· Phase 2
Test of Propranolol for Severe Behaviors in Autism

This study tests a medication called propranolol to see if it can reduce aggression and other severe behaviors in adolescents and adults with autism. It might be an option if you have frequent and serious challenging behaviors that other treatments haven't helped.

Staten Island, New York
NCT05864508Not yet recruiting· Phase 2
Oxytocin nasal spray for challenging behaviors in autism

This trial tests whether adding oxytocin nasal spray to standard behavioral therapy can help reduce challenging behaviors in children with autism and intellectual disability. It aims to see if the treatment is safe and practical.

Toulouse
NCT07433517Not yet recruiting· Early Phase 1
Cell therapy for severe autism-related self-injury and aggression

This trial tests a new cell-based treatment (called VGN-Ex05e) for young people with autism who have severe self-injury or aggression that hasn't improved with standard treatments. The treatment is given as a one-time injection into a specific area of the brain (nucleus accumbens) to help calm these behaviors.

NCT05664789Recruiting· Phase 2/Phase 3
N-acetylcysteine for autism behaviors in children

This trial studies whether N-acetylcysteine, a medicine taken by mouth, can improve autism-related restricted and repetitive behaviors in children. It looks at children who are showing at least moderate severity in these behaviors and may involve brain testing for safety reasons.

Palo Alto, California
NCT07393893Enrolling by invitation
Parent intervention trial for young children with autism

This trial tests a program to help parents support children with autism. It aims to improve child development and family well-being through parent training and guidance.

Chengdu, Sichuan
NCT05916339Recruiting· Phase 4
Managing ADHD symptoms in autistic children with a study plan

This Phase 4 study looks at how to manage ADHD symptoms in children and teens who also have autism. It may help your child’s care team learn what treatment routines work best in real life settings.

Irvine, California

Hear when a new Challenging Behavior trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.